➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Harvard Business School
Express Scripts
Mallinckrodt
Baxter

Last Updated: August 10, 2020

DrugPatentWatch Database Preview

Pharmaceutical drugs supplied by: ApoPharma USA, Inc.

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

ApoPharma USA, Inc.

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Apotex ALKERAN melphalan TABLET;ORAL 014691 NDA ApoPharma USA, Inc. 52609-0001-5 50 TABLET, FILM COATED in 1 BOTTLE (52609-0001-5)
Chiesi FERRIPROX deferiprone TABLET;ORAL 021825 NDA ApoPharma USA, Inc. 52609-0006-1 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (52609-0006-1)
Chiesi FERRIPROX deferiprone TABLET;ORAL 021825 NDA ApoPharma USA, Inc. 52609-0007-5 50 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (52609-0007-5)
Apotex ALKERAN melphalan hydrochloride INJECTABLE;INJECTION 020207 NDA ApoPharma USA, Inc. 52609-3001-0 1 KIT in 1 CARTON (52609-3001-0) * 10 mL in 1 VIAL, SINGLE-DOSE (52609-3002-0) * 10 mL in 1 VIAL, SINGLE-USE (52609-3003-0)
Chiesi FERRIPROX deferiprone SOLUTION;ORAL 208030 NDA ApoPharma USA, Inc. 52609-4502-7 500 mL in 1 BOTTLE, PLASTIC (52609-4502-7)
Gland Pharma Ltd DEFEROXAMINE MESYLATE deferoxamine mesylate INJECTABLE;INJECTION 207384 ANDA ApoPharma USA, Inc. 52609-4504-6 4 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (52609-4504-6)
Gland Pharma Ltd DEFEROXAMINE MESYLATE deferoxamine mesylate INJECTABLE;INJECTION 207384 ANDA ApoPharma USA, Inc. 52609-4505-6 4 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (52609-4505-6)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
AstraZeneca
Harvard Business School
Dow
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.